ArticleHealth economics review2026

Cost-utility analysis of three PD-1 inhibitors combined with chemotherapy in the first-line treatment of locally advanced or metastatic esophageal squamous carcinoma in China.

Li Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.